Video

DSM-5 expected to be more 'user-friendly'


 

EXPERT ANALYSIS FROM THE AMERICAN COLLEGE OF PSYCHIATRISTS ANNUAL MEETING

When the DSM-5 is unveiled at the annual meeting of the American Psychiatric Association in May, Dr. David J. Kupfer hopes that clinicians will find a more user-friendly document compared with the DSM-IV.

At the annual meeting of the American College of Psychiatrists, Dr. Kupfer, chair of the DSM-5 task force and professor of psychiatry at the University of Pittsburgh, said the DSM-IV’s organizational structure "failed to reflect shared features or symptoms of related disorders and diagnostic groups, like psychotic disorders with bipolar disorders or internalizing and externalizing disorders. This led us to restructure DSM-5 in a way that better reflects these interrelationships, within and across diagnostic chapters."

The DSM-IV also was limited, he said, because it promoted a strict categorical approach to making diagnoses, the notion that "either you have it or you don’t," Dr. Kupfer said at the annual meeting of the American College of Psychiatrists. "This tends not to capture the variations of disorders that we see in real life. As a consequence, more ‘not otherwise specified’ designations were used than probably were necessary." Nor did the DSM-IV adequately address lifespan perspective, he said, including variations of symptom presentation across the developmental trajectory, or cultural perspectives. "That’s a deficiency, I think."

The 20-chapter DSM-5 – an 8-year effort that involved input from about 400 clinicians at 13 international conferences – "represents an opportunity to integrate cross-cutting symptomatic descriptions which better reflect the true presentation of disorders and may reduce reliance on ‘not otherwise specified’ diagnoses," Dr. Kupfer said. Its chapter structure, criteria revisions, and text outline "actively address age and development as part of diagnosis and classification," he said. "Culture is similarly discussed more explicitly to bring greater attention to cultural variations in symptom presentations."

Dr. Kupfer described the DSM-5 as a "living document," meaning that it will be more amenable to updates in psychiatry and neuroscience, and less susceptible to becoming outdated, compared with its predecessors. "We do not want to wait for 20 or 25 years for the next change to be made in the DSM," he emphasized. "We want to take advantage of advances that are likely to be made in certain areas of diagnostic nomenclature that can be put into the DSM and give us more objective criteria than we currently have for most of our disorders."

At the meeting, Dr. Kupfer and Dr. Darrel A. Regier, vice chair of the DSM-5 task force, highlighted select changes from DSM-IV that clinicians can expect to find in DSM-5. For example, autism spectrum disorder is now a single diagnosis. "The concern within the clinical and research field was that it was not possible to consistently break out autism, Asperger’s disorder, and pervasive developmental disorder not otherwise specified," said Dr. Regier, director of the American Psychiatric Institute for Research and Education and director of the division of research at the American Psychiatric Association. "There was a universal agreement that this needed to be seen as a spectrum of disorders that would be assessed on the basis of two domains: One was social communication and the other was restricted repetitive behaviors and interests.

"If one would rank people on the basis of their impairment in those two areas, that would be much more informative for guiding treatment and educational programs. That was a critical concern," he said.

The DSM-5 includes the addition of a specifier for all neurodevelopmental disorders associated with known medical or genetic conditions, or environmental factors. Specifiers are also included for specific learning disorders in reading, writing, and math.

In schizophrenia, special treatment of bizarre delusions and special hallucinations in criterion A (characteristic symptoms) has been eliminated. "With DSM-IV, you could get a diagnosis of schizophrenia if you just had bizarre delusions, but research shows that there is very poor reliability in separating bizarre and nonbizarre delusions," Dr. Regier said. Now, at least one psychotic symptom is required for a diagnosis of schizophrenia. "You have to have delusions, hallucinations, or disorganized speech in order to meet criteria," he said.

Dr. Darrel Regier

In a related development, catatonia exists as a specifier for neurodevelopmental, psychotic, mood, and other mental disorders, as well as for catatonia due to another medical condition.

In bipolar disorder, increased energy/activity as a criterion A symptom of hypomania/mania has been included. "Although those aspects have been included as symptoms previously, what is now recommended is that they become part of the criterion A, along with changes in mood," Dr. Kupfer said. The DSM-5 also includes a "with mixed features" specifier for manic, hypomanic, and major depressive episodes, which "better reflects what clinicians see and what they need to diagnose."

Pages

Recommended Reading

Medicaid's share of state budgets nears 24%
MDedge Psychiatry
States spend little tobacco revenue on prevention
MDedge Psychiatry
Doctors support bipartisan SGR repeal bill
MDedge Psychiatry
Medicaid expansion, Medicare reform: The Policy & Practice Podcast
MDedge Psychiatry
VIDEO: Happy patients, happy physician practice
MDedge Psychiatry
IOM report addresses global problem of poor-quality drugs
MDedge Psychiatry
SGR fix coming soon? The Policy & Practice Podcast
MDedge Psychiatry
Choosing Wisely: More tests questioned in second round
MDedge Psychiatry
HHS defines essential benefits under ACA
MDedge Psychiatry
Sequester means 2% Medicare cut on April 1
MDedge Psychiatry